Dra. María Alejandra Lavanderos Villagrán

Doctora en Ciencias Farmacéuticas

ORCID: 0000-0001-6167-0508

Área de investigación:

Farmacocinética
Tecnología Farmacéutica
Farmacogenética
Farmacogenómica

Contacto: mlavanderos@ubiobio.cl / +56-246-3276

2025
Cerpa, L. C., Sandoval, C., Escalante, P., Cayún, J. P., Lavanderos, M. A., Alarcón-Concha, C., Kaempfe, G., Moreno-Tapia, D., Quiroz, C. S., Gutierrez-Cáceres, C., Barajas, O., Müller, B., Colombo, A., Donoso, G., Nuñez, A., Varela, N. M., & Quiñones, L. A. (2025). Genetic variants and clinical determinants affecting the response to 5-fluorouracil-based treatment in Chilean patients with advanced colorectal cancer. Frontiers in Oncology, 15, 1589724. https://doi.org/10.3389/fonc.2025.1589724

2023
Salas-Hernández, A., Galleguillos, M., Carrasco, M., López-Cortés, A., Redal, M. A., Fonseca-Mendoza, D., Esperón, P., González-Martínez, F., Lares-Asseff, I., Lazarowski, A., Loera-Castañeda, V., Remírez, D., Martínez, M. F., Vargas, R., Rios-Santos, F., Macho, A., Cayún, J. P., Perez, G. R., Gutierrez, C., . . . Quiñones, L. A. (2023). An updated examination of the perception of barriers for pharmacogenomics implementation and the usefulness of drug/gene pairs in Latin America and the Caribbean. Frontiers in Pharmacology, 14, 1175737. https://doi.org/10.3389/fphar.2023.1175737

2021
Cordova-Delgado, M., Bravo, M. L., Cumsille, E., Hill, C. N., Muñoz-Medel, M., Pinto, M. P., Retamal, I. N., Lavanderos, M. A., Miquel, J. F., Rodriguez-Fernandez, M., Liao, Y., Li, Z., Corvalán, A. H., Armisén, R., Garrido, M., Quiñones, L. A., & Owen, G. I. (2021). A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherapy in gastric cancer. BMC Cancer, 21, 1030. https://doi.org/10.1186/s12885-021-08745-0

Scroll al inicio